Close

Analyst Ratings for Protalix BioTherapeutics (PLX)

PLX Rating Summary

  |   Expand Research on PLX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.8 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/30/2011 Auriga N/A New Coverage Buy
(N/A)
8.00
(N/A)
5.85
(5.10)
-12.82% Details
10/13/2011 Morgan Joseph N/A New Coverage Hold
(N/A)
N/A
(N/A)
4.89
(5.10)
4.29% Details